F865-0302 Screening compound: N-(4-methylphenyl)-5-[4-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide

F865-0302 Screening compound: N-(4-methylphenyl)-5-[4-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide
F865-0302 Screening compound: N-(4-methylphenyl)-5-[4-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F865-0302
N-(4-methylphenyl)-5-[4-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F865-0302

Molecular Formula

C24H32N6O4S (C24 H32 N6 O4 S)

Compound Name

N-(4-methylphenyl)-5-[4-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide

IUPAC name

N-(4-methylphenyl)-5-[4-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-134-thiadiazole-2-carboxamide

SMILES

Cc(cc1)ccc1NC(c1nnc(C(N2CCC(CC(NCCN3CCOCC3)=O)CC2)=O)s1)=O

InChI

InChI=1S/C24H32N6O4S/c1-17-2-4-19(5-3-17)26-21(32)22-27-28-23(35-22)24(33)30-9-6-18(7-10-30)16-20(31)25-8-11-29-12-14-34-15-13-29/h2-5,18H,6-16H2,1H3,(H,25,31)(H,26,32)

InChI Key

BXSUPGGUQAEROU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14968907

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

500.62

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.332

Distribution Coefficient, logD

1.255

Water Solubility, LogSw

-2.25

Polar Surface Area

99.414

Acid Dissociation Constant (pKa)

10.04

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

F865-0302 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F865-0302 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F865-0302?
Check Price and Availability of F865-0302, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F865-0302 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F865-0302
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F865-0302
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F865-0302 available by request